NDC 0078-1056

COSENTYX

Secukinumab

COSENTYX is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Secukinumab.

• Product ID: 0078-1056_1b52f8f5-c6db-4d83-ac31-f566d2bf99a4
• NDC: 0078-1056
• Product Type: Human Prescription Drug
• Proprietary Name: COSENTYX
• Generic Name: Secukinumab
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2015-01-21
• Marketing Category: BLA /
• Application Number: BLA125504
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: SECUKINUMAB
• Active Ingredient Strength: 75 mg/.5mL
• Pharm Classes: Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0078-1056-97

1 SYRINGE, GLASS in 1 CARTON (0078-1056-97) > .5 mL in 1 SYRINGE, GLASS

• Marketing Start Date: 2021-05-28
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "COSENTYX" or generic name "Secukinumab"

NDC	Brand Name	Generic Name
0078-0639	COSENTYX	secukinumab
0078-1056	COSENTYX	secukinumab